Brendan Smith
Plus aucun poste en cours
Fortune : 345 708 $ au 31/03/2024
Profil
Actuellement, Brendan Smith occupe le poste de Senior VP, Chief Financial & Accounting Officer chez CRISPR Therapeutics AG. Dans le passé, M. Smith a été directeur financier et responsable de la stratégie d'entreprise chez Translate Bio, Inc. et partenaire et directeur associé chez The Boston Consulting Group, Inc. Il a obtenu un diplôme de premier cycle à l'Institut polytechnique de Worcester et un MBA à la Harvard Business School.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CRISPR THERAPEUTICS AG
0,01% | 31/03/2023 | 5 072 ( 0,01% ) | 345 708 $ | 31/03/2024 |
Anciens postes connus de Brendan Smith
| Sociétés | Poste | Fin |
|---|---|---|
| CRISPR THERAPEUTICS AG | Director of Finance/CFO | 14/03/2023 |
| TRANSLATE BIO, INC. | Director of Finance/CFO | 14/09/2021 |
The Boston Consulting Group, Inc.
 The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/03/2021 |
| Pfizer AG | Director/Board Member | - |
Formation de Brendan Smith
| Worcester Polytechnic Institute | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CRISPR THERAPEUTICS AG | Health Technology |
| Entreprise privées | 3 |
|---|---|
Translate Bio, Inc.
 Translate Bio, Inc. BiotechnologyHealth Technology Translate Bio, Inc. engages in the research and development of therapeutic drugs. It focuses on developing medicines to treat diseases caused by protein or gene dysfunction. Its lead product candidate, MRT5005 is designed for the treatment of cystic fibrosis. The company was founded by Arthur M. Krieg and Jeannie T. Lee in 2011 and is headquartered in Lexington, MA. | Health Technology |
The Boston Consulting Group, Inc.
The Boston Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services The Boston Consulting Group, Inc. engages in the provision of management consulting services. It specializes in automotive and mobility; biopharmaceuticals; consumer products; education; oil and gas; power and utilities; engineered products and infrastructure; financial institutions; and health care payers, providers, and services. It offers big data and advanced analytics; change management; client learning and enablement; and corporate development and financial services. The company was founded by Bruce Doolin Henderson in 1963 and is headquartered in Boston, MA. | Commercial Services |
| Pfizer AG |
